famotidine has been researched along with Dysphagia in 2 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Excerpt | Relevance | Reference |
---|---|---|
"Heartburn, regurgitation and dysphagia were hardly found in any group at 8 weeks after 15 mg or 30 mg lansoprazole treatment." | 5.11 | Management of symptoms in step-down therapy of gastroesophageal reflux disease. ( Iida, T; Kishikawa, H; Mine, S; Tabata, T; Tanaka, Y, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Stokes, NA | 1 |
Lemos, JP | 1 |
Mine, S | 1 |
Iida, T | 1 |
Tabata, T | 1 |
Kishikawa, H | 1 |
Tanaka, Y | 1 |
1 trial available for famotidine and Dysphagia
Article | Year |
---|---|
Management of symptoms in step-down therapy of gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Deglutition Disorders; Endosonography; Enzyme Inhibit | 2005 |
1 other study available for famotidine and Dysphagia
Article | Year |
---|---|
Male patient with throat swelling and painful swallowing.
Topics: Adenoids; Adult; Angioedema; Anti-Inflammatory Agents; Deglutition Disorders; Dexamethasone; Diphenh | 2013 |